Jul 25 |
Eli Lilly and Company: The Floodgates To Growth Keep Opening, A Big Win In China
|
Jul 25 |
Viking sends Lilly, Novo lower as obesity drug enters late-stage program
|
Jul 24 |
What Lies in Store for Healthcare ETFs in Q2 Earnings?
|
Jul 24 |
Jim Cramer Thinks Eli Lilly (LLY) Has a ‘Huge Lead’ in Weight Loss Industry, Stock is on ‘Sale’
|
Jul 24 |
3 Dividend Growth Stocks That Have Doubled Their Payouts in 5 Years
|
Jul 23 |
Time for Healthcare ETFs?
|
Jul 23 |
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
|
Jul 22 |
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
|
Jul 22 |
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment
|
Jul 22 |
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
|